Conference Presentation, Panel
Mental Health Innovations for the 21st Century
- Mental illness is projected to remain highly visible for the foreseeable future, driven by a "tidal wave" of behavioral illnesses and stress resulting from the pandemic, economic uncertainty, fear, loss, and increased alcohol consumption, with fetal alcohol exposure impacts expected within six to nine months.
- Long-term uncertainties surround the pandemic's full ripple effects, including unknown outcomes on children's healthy maturation due to screen time and lack of social encounters, as well as the development of PTSD and mental health issues in high school and early college populations.
- Telehealth adoption has accelerated significantly by necessity; however, future care will require advancing quality rather than replicating pre-COVID conditions, utilizing telemedicine as a tool alongside long-acting injectable medicines to minimize face-to-face interactions, while addressing abysmal continuity of care.
- Vaccine and treatment availability is anticipated with a vaccine potentially arriving late this year or early next year and treatments in a few months, though no cure or "silver bullet" for conditions like schizophrenia or bipolar disorder is expected soon, and vaccines may lack 100% universal effectiveness or availability.
- Systematic permanent changes are planned to address regulatory inertia, which may be loosened despite potential mistakes in the rapid speed of drug development, while acknowledging that over a thousand new cancer medicines are in development compared to a single potential new schizophrenia drug costing around $1,000 monthly versus cancer drugs at $20,000 monthly.
- Significant barriers to care include a current shortage of mental health workers, skewed payment incentives that make launching novel anti-psychotics in Europe impossible, and global public skepticism of science.
- Strategic plans focus on collaboration across industry and philanthropy to move all three sectors in unison, training community members to build trust rather than using outsiders, and expanding capacity to address policy enveloping the system beyond just creating physical space.
- Clinical development faces challenges regarding disparities in clinical trials and a lack of input from underserved communities, necessitating a roadmap that includes focusing on staff mental health as a priority and avoiding the loss of patients during critical interactions.